Our news

  • Orlagh O'Shea, who is an ESI fellow, published a new review with Chris Cates and Liz Stovold from the Cochrane Airways Editroial base team. Orlagh said that the take-home message from the review is "As long as salmeterol or formoterol are in a combined inhaler with an inhaled steroid we did not identify any safety issues which would affect the...
    April 14 2021
  • Review authors wanted to know if exercise training improves exercise tolerance, quality of life, or symptoms, and if it reduces the number of future flare-ups ('exacerbations'), for people with bronchiectasis compared to people who did not do exercise training. They looked at studies involving adults and children with stable disease and patients...
    April 1 2021
  • Pulmonary arterial hypertension is a devastating disease that leads to right heart failure and premature death. Endothelin receptor antagonists are a class of strong vasodilators (medications that open (dilate) blood vessels) capable of stopping the process of cell division, which could dilate and result in a favourable pulmonary arterial...
    March 29 2021
  • How does using technology to deliver pulmonary rehabilitation (PR) compare to centre‐based PR, or no PR in people with chronic lung disease?Bottom lineThis review suggests that primary pulmonary rehabilitation, or maintenance rehabilitation, delivered via telerehabilitation for people with chronic respiratory disease achieves outcomes similar to...
    February 2 2021
  • Bottom linePulmonary rehabilitation probably improves exercise capacity, symptoms and quality of life, and can be performed safely in people with ILD, including those with IPF. Results from this updated Cochrane Review support the inclusion of pulmonary rehabilitation as part of the management for people with ILD. Future studies should explore...
    February 2 2021
  • We recently held a lovely online farewell gathering for our Coordinating Editor, Chris Cates. Chris has retired after being involved with the group for 25 years. Chris wrote one of the very first reviews published by Airways. Chris will continue to give advice and support to colleagues as he becomes Emeritus Co-ordinating Editor at Cochrane...
    January 27 2021
  • Which preventative antibiotic is effective and safe for reducing exacerbations, improving quality of life, and reducing serious side effects in people with COPD?Bottom lineAlthough these NMAs show some benefit of using macrolides, they are based on a limited number of studies, and concerns remain about antibiotic resistance with long‐term use of...
    January 18 2021
  • Anti‐IL‐5 therapies for chronic obstructive pulmonary diseaseThis review aimed to assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD. The review used standard Cochrane methods.Exacerbations of chronic obstructive pulmonary...
    December 10 2020
  • The Cochrane Airways Priority Setting Group (CAPSG), formed of stakeholders including patients and carers, in conjunction with the Editorial Board, have prioritised some topics for new Cochrane Reviews. These are available here, together with details of how to apply to write a review (which requires completion of a review proposal form). For a...
    November 11 2020
  • What is myofunctional therapy?Myofunctional therapy teaches people to do daily exercises to strengthen their tongue and throat muscles. Myofunctional therapy may reduce the intensity of the OSA symptoms and reduce daytime sleepiness on its own, or combined with CPAP. Therapy can include exercises involving several muscles and areas of the mouth,...
    November 9 2020

Pages

Subscribe to Our news